0.2362
price down icon9.33%   -0.0243
pre-market  시장 영업 전:  .26   0.0238   +10.08%
loading
전일 마감가:
$0.2605
열려 있는:
$0.2567
하루 거래량:
672.06K
Relative Volume:
0.56
시가총액:
$14.61M
수익:
$1.16M
순이익/손실:
$-39.74M
주가수익비율:
-0.381
EPS:
-0.62
순현금흐름:
$-35.02M
1주 성능:
+4.28%
1개월 성능:
+8.25%
6개월 성능:
-51.80%
1년 성능:
-84.76%
1일 변동 폭
Value
$0.2275
$0.2613
1주일 범위
Value
$0.2275
$0.275
52주 변동 폭
Value
$0.1406
$1.93

Glycomimetics Inc Stock (GLYC) Company Profile

Name
명칭
Glycomimetics Inc
Name
전화
240-243-1201
Name
주소
9708 MEDICAL CENTER DRIVE, ROCKVILLE, MD
Name
직원
26
Name
트위터
Name
다음 수익 날짜
2025-03-31
Name
최신 SEC 제출 서류
Name
GLYC's Discussions on Twitter

GLYC을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
GLYC
Glycomimetics Inc
0.2362 14.61M 1.16M -39.74M -35.02M -0.62
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
503.50 126.09B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
568.91 64.01B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
629.51 36.63B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
257.19 30.64B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
249.77 27.24B 3.81B -644.79M -669.77M -6.24

Glycomimetics Inc Stock (GLYC) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-03-21 개시 Cantor Fitzgerald Overweight
2024-07-26 다운그레이드 TD Cowen Buy → Hold
2023-12-22 개시 CapitalOne Overweight
2021-11-12 업그레이드 Jefferies Hold → Buy
2019-11-14 개시 ROTH Capital Buy
2019-08-05 다운그레이드 Jefferies Buy → Hold
2019-08-05 다운그레이드 Piper Jaffray Overweight → Neutral
2019-08-05 다운그레이드 SunTrust Buy → Hold
2019-04-12 개시 Piper Jaffray Overweight
2018-12-18 개시 H.C. Wainwright Buy
2016-07-26 개시 SunTrust Buy
2015-03-17 재확인 Stifel Buy
모두보기

Glycomimetics Inc 주식(GLYC)의 최신 뉴스

pulisher
Apr 29, 2025

GlycoMimetics Amends Merger Agreement With Crescent Biopharma - Investing.com

Apr 29, 2025
pulisher
Apr 28, 2025

GlycoMimetics, Inc. (GLYC) Stock Report: Analyst Ratings Signal Potential in Biotech Space - DirectorsTalk Interviews

Apr 28, 2025
pulisher
Apr 25, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 25, 2025
pulisher
Apr 25, 2025

A Look at GlycoMimetics Inc (GLYC) Shares in the Recent Past Indicates Growth - Sete News

Apr 25, 2025
pulisher
Apr 24, 2025

GLYC Shares Experience Surge in Value - knoxdaily.com

Apr 24, 2025
pulisher
Apr 23, 2025

GlycoMimetics (NASDAQ:GLYC) Stock Price Passes Below 200 Day Moving Average – Time to Sell? - Defense World

Apr 23, 2025
pulisher
Apr 23, 2025

GlycoMimetics Inc (GLYC) Stock: A Year of Stock Market Ups and Downs - investchronicle.com

Apr 23, 2025
pulisher
Apr 23, 2025

Understanding GLYC stock ratios for better investment decisions - uspostnews.com

Apr 23, 2025
pulisher
Apr 23, 2025

GlycoMimetics (NASDAQ:GLYC) Now Covered by StockNews.com - Defense World

Apr 23, 2025
pulisher
Apr 15, 2025

Wellington Management Group LLP Makes New Investment in GlycoMimetics, Inc. (NASDAQ:GLYC) - Defense World

Apr 15, 2025
pulisher
Apr 15, 2025

StockNews.com Begins Coverage on GlycoMimetics (NASDAQ:GLYC) - Defense World

Apr 15, 2025
pulisher
Apr 08, 2025

GlycoMimetics, Inc. Announces Efficacy and Safety Data from Phase 1/2 Clinical Study of Uproleselan Published in BLOOD - MarketScreener

Apr 08, 2025
pulisher
Apr 07, 2025

GlycoMimetics (NASDAQ:GLYC) Now Covered by Analysts at StockNews.com - Defense World

Apr 07, 2025
pulisher
Apr 03, 2025

Form 425 GLYCOMIMETICS INC Filed by: GLYCOMIMETICS INC - StreetInsider

Apr 03, 2025
pulisher
Apr 03, 2025

Crescent Biopharma Appoints Joshua Brumm as Chief Executive Officer and Expands Leadership Team to Advance Pipeline of Potentially Best-in-Class Oncology Therapeutics - Quantisnow

Apr 03, 2025
pulisher
Mar 23, 2025

GLYCOMIMETICS Earnings Preview: Recent $GLYC Insider Trading, Hedge Fund Activity, and More - Nasdaq

Mar 23, 2025
pulisher
Mar 23, 2025

Cantor Fitzgerald Begins Coverage on GlycoMimetics (NASDAQ:GLYC) - Defense World

Mar 23, 2025
pulisher
Mar 22, 2025

Cantor Fitzgerald maintains Overweight on GlycoMimetics stock By Investing.com - Investing.com Australia

Mar 22, 2025
pulisher
Mar 22, 2025

Cantor Fitzgerald Initiates Coverage of GlycoMimetics (GLYC) with Overweight Recommendation - MSN

Mar 22, 2025
pulisher
Mar 22, 2025

GlycoMimetics (NASDAQ:GLYC) Coverage Initiated by Analysts at StockNews.com - Defense World

Mar 22, 2025
pulisher
Mar 21, 2025

Cantor Fitzgerald maintains Overweight on GlycoMimetics stock - Investing.com India

Mar 21, 2025
pulisher
Mar 21, 2025

Cantor Fitzgerald Initiates GlycoMimetics at Overweight -March 21, 2025 at 07:18 am EDT - Marketscreener.com

Mar 21, 2025
pulisher
Mar 20, 2025

GlycoMimetics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) - Business Wire

Mar 20, 2025
pulisher
Mar 19, 2025

GlycoMimetics, Inc. (NASDAQ:GLYC) Short Interest Update - Defense World

Mar 19, 2025
pulisher
Mar 14, 2025

StockNews.com Initiates Coverage on GlycoMimetics (NASDAQ:GLYC) - Defense World

Mar 14, 2025
pulisher
Mar 08, 2025

GlycoMimetics, Inc. to Host Earnings Call - ACCESS Newswire

Mar 08, 2025
pulisher
Mar 05, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CMRX and GLYC on Behalf of Shareholders - The Malaysian Reserve

Mar 05, 2025
pulisher
Mar 01, 2025

GlycoMimetics, Inc. Announces Board Resignations -February 25, 2025 at 05:00 pm EST - Marketscreener.com

Mar 01, 2025
pulisher
Feb 25, 2025

GlycoMimetics Says Following Termination, Co Will Not Have Any Material Financial Or Other Obligations Under Agreement - TradingView

Feb 25, 2025
pulisher
Feb 25, 2025

GlycoMimetics ends key agreement; board members, executives depart By Investing.com - Investing.com South Africa

Feb 25, 2025
pulisher
Feb 25, 2025

GlycoMimetics ends key agreement; board members, executives depart - Investing.com

Feb 25, 2025
pulisher
Feb 25, 2025

GlycoMimetics Faces Leadership Changes Amid Board Resignations - TipRanks

Feb 25, 2025
pulisher
Feb 19, 2025

US Penny Stocks To Watch In February 2025 - Yahoo Finance

Feb 19, 2025
pulisher
Feb 18, 2025

Why GCL Global Holdings Shares Are Trading Higher By Around 107%; Here Are 20 Stocks Moving Premarket - Benzinga

Feb 18, 2025
pulisher
Feb 18, 2025

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

Feb 18, 2025
pulisher
Feb 18, 2025

GlycoMimetics (NASDAQ:GLYC) Coverage Initiated at StockNews.com - Defense World

Feb 18, 2025
pulisher
Feb 17, 2025

Top 5 Biotech Stocks That Got Most Retail Buzz Last Week - NewsBreak

Feb 17, 2025
pulisher
Feb 15, 2025

GlycoMimetics adjusts merger terms with Crescent Biopharma - MSN

Feb 15, 2025
pulisher
Feb 15, 2025

GlycoMimetics And GENFIT Announce Significant Agreement Amendments - Evrim Ağacı

Feb 15, 2025
pulisher
Feb 14, 2025

GlycoMimetics adjusts merger terms with Crescent Biopharma By Investing.com - Investing.com UK

Feb 14, 2025
pulisher
Feb 13, 2025

GLYCOMIMETICS INC SEC 10-K Report - TradingView

Feb 13, 2025
pulisher
Feb 05, 2025

Glycomimetics, Inc. Announces Cessation of Brian Hahn as Chief Financial Officer, No Later Than March 31, 2025 - Marketscreener.com

Feb 05, 2025

Glycomimetics Inc (GLYC) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$20.79
price up icon 0.78%
$71.40
price up icon 2.20%
$32.71
price up icon 0.52%
$23.62
price down icon 2.03%
$104.00
price up icon 0.00%
biotechnology ONC
$249.77
price up icon 0.12%
자본화:     |  볼륨(24시간):